Inclisiran: the ‘extremely unusual’ political influence behind the novel drug’s approval
A year-long investigation by The Pharmaceutical Journal has raised questions over the influence of the UK government and NHS England on the National Institute for Health and Care Excellence’s approval of cholesterol-lowering drug inclisiran.…
